Thermo Fisher Scientific Inc.
TMO
$424.43
-$2.23-0.52%
NYSE
| 12/31/2024 | 09/28/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.52% | 0.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.52% | 0.54% | |||
| Cost of Revenue | 4.63% | 1.10% | |||
| Gross Profit | 11.69% | -0.25% | |||
| SG&A Expenses | 4.91% | -4.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.18% | -0.26% | |||
| Operating Income | 18.13% | 4.36% | |||
| Income Before Tax | 14.17% | 2.79% | |||
| Income Tax Expenses | 51.52% | -22.66% | |||
| Earnings from Continuing Operations | 11.90% | 4.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.27% | 5.30% | |||
| EBIT | 18.13% | 4.36% | |||
| EBITDA | 13.60% | 0.88% | |||
| EPS Basic | 12.27% | 5.30% | |||
| Normalized Basic EPS | 22.38% | 7.21% | |||
| EPS Diluted | 12.47% | 5.20% | |||
| Normalized Diluted EPS | 22.70% | 6.93% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.26% | 0.26% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.12% | -0.04% | |||